Exagen, Inc. (XGN)
7.39
-0.13
(-1.73%)
USD |
NASDAQ |
Aug 28, 16:00
7.38
-0.01
(-0.14%)
After-Hours: 20:00
Exagen Total Long Term Debt (Quarterly) : 26.68M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.68M |
| March 31, 2026 | 25.89M |
| December 31, 2025 | 26.44M |
| September 30, 2025 | 26.98M |
| June 30, 2025 | 24.04M |
| March 31, 2025 | 22.31M |
| December 31, 2024 | 22.27M |
| September 30, 2024 | 22.49M |
| June 30, 2024 | 22.84M |
| March 31, 2024 | 22.47M |
| December 31, 2023 | 22.74M |
| September 30, 2023 | 23.62M |
| June 30, 2023 | 23.93M |
| March 31, 2023 | 34.21M |
| December 31, 2022 | 35.01M |
| September 30, 2022 | 34.48M |
| June 30, 2022 | 34.32M |
| March 31, 2022 | 34.27M |
| December 31, 2021 | 28.06M |
| September 30, 2021 | 27.87M |
| June 30, 2021 | 27.62M |
| March 31, 2021 | 27.26M |
| December 31, 2020 | 26.97M |
| Date | Value |
|---|---|
| September 30, 2020 | 26.72M |
| June 30, 2020 | 26.49M |
| March 31, 2020 | 26.29M |
| December 31, 2019 | 26.09M |
| September 30, 2019 | 25.86M |
| June 30, 2019 | 26.52M |
| March 31, 2019 | 27.74M |
| December 31, 2018 | 26.20M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2015 | 0.531M |
| September 30, 2015 | 22.03M |
| June 30, 2015 | 1.42M |
| March 31, 2015 | 21.52M |
| December 31, 2014 | 19.98M |
| September 30, 2014 | 19.71M |
| June 30, 2014 | 15.39M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 10.00M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 203.20M |
| BioRestorative Therapies, Inc. | 0.00 |
| CareDx, Inc. | 13.20M |
| Natera, Inc. | 143.07M |
| Sera Prognostics, Inc. | 3.001M |